Industry
Medical - Devices
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Loading...
Open
225.05
Mkt cap
21B
Volume
1.1M
High
225.05
P/E Ratio
38.21
52-wk high
248.24
Low
211.31
Div yield
0.01
52-wk low
195.47
Portfolio Pulse from Avi Kapoor
October 24, 2024 | 6:07 pm
Portfolio Pulse from Benzinga Newsdesk
October 24, 2024 | 4:25 pm
Portfolio Pulse from Benzinga Insights
October 24, 2024 | 2:00 pm
Portfolio Pulse from Benzinga Newsdesk
October 24, 2024 | 1:54 pm
Portfolio Pulse from Nabaparna Bhattacharya
September 03, 2024 | 4:11 pm
Portfolio Pulse from Benzinga Insights
September 03, 2024 | 4:00 pm
Portfolio Pulse from Benzinga Newsdesk
September 03, 2024 | 2:25 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 10:23 am
Portfolio Pulse from Benzinga Insights
August 07, 2024 | 9:00 pm
Portfolio Pulse from Benzinga Newsdesk
August 07, 2024 | 8:41 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.